• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    LFW Photonics Market Index
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    Minerva Neuroscie (NQ: NERV )

    2.740 UNCHANGED
    Streaming Delayed Price Updated: 3:59 PM EDT, Aug 30, 2024 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 0
    Open 2.740
    Bid (Size) 2.750 (1)
    Ask (Size) 2.830 (10)
    Prev. Close 2.740
    Today's Range 2.740 - 2.740
    52wk Range 2.260 - 13.49
    Shares Outstanding 6,993,406
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    NERV Stock Earnings: Minerva Neurosciences Misses EPS for Q2 2024
    NERV stock results show that Minerva Neurosciences missed analyst estimates for earnings per share the second quarter of 2024. 
    Via InvestorPlace
    Minerva Neurosciences Reports Second Quarter 2024 Financial Results and Business Updates
    From Minerva Neurosciences, Inc
    Via GlobeNewswire

    Performance

    YTD
    -55.45%
    -55.45%
    1 Month
    -2.14%
    -2.14%
    3 Month
    -5.19%
    -5.19%
    6 Month
    +6.20%
    +6.20%
    1 Year
    -63.99%
    -63.99%

    More News

    Read More
    NERV Stock Earnings: Minerva Neurosciences Beats EPS for Q1 2024
    Via InvestorPlace
    Minerva Neurosciences Reports First Quarter 2024 Financial Results and Business Updates
    From Minerva Neurosciences, Inc
    Via GlobeNewswire
    Minerva Neurosciences: Q4 Earnings Insights
    Via Benzinga
    Dow Dips Over 100 Points; J.M. Smucker Posts Upbeat Earnings
    Via Benzinga
    Topics Stocks
    Exposures US Equities
    Why Helix Energy Solutions Shares Are Trading Lower By 11%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
    Via Benzinga
    Regulatory Setback For Minerva Neurosciences' Schizophrenia Treatment Candidate, FDA Asks For More Data
    Via Benzinga
    Exposures Product Safety
    12 Health Care Stocks Moving In Tuesday's Intraday Session
    Via Benzinga
    Crude Oil Gains 1%; Macy's Plans To Close 150 Stores
    Via Benzinga
    Topics Stocks
    Exposures Fossil Fuels US Equities
    Nasdaq Rises 50 Points; Lowe's Earnings Top Views
    Via Benzinga
    Topics Stocks
    Exposures US Equities
    Minerva Neurosciences Receives Complete Response Letter from FDA for New Drug Application for Roluperidone for the Treatment of Negative Symptoms in Patients with Schizophrenia
    From Minerva Neurosciences, Inc
    Via GlobeNewswire
    Minerva Neurosciences Reports Fourth Quarter and Fiscal Year 2023 Financial Results and Business Updates
    From Minerva Neurosciences, Inc
    Via GlobeNewswire
    12 Health Care Stocks Moving In Thursday's Intraday Session
    Via Benzinga
    12 Health Care Stocks Moving In Monday's After-Market Session
    Via Benzinga
    Minerva Neurosciences Reports 2023 Third Quarter Financial Results and Business Updates
    From Minerva Neurosciences, Inc
    Via GlobeNewswire
    Minerva Neurosciences Reports 2023 Second Quarter Financial Results and Business Updates
    From Minerva Neurosciences, Inc
    Via GlobeNewswire
    10 Short Squeeze Stocks To Watch: Baosheng Media, Toro Corp, Getty Images And More
    Via Benzinga
    Top 5 Health Care Stocks That May Collapse This Quarter
    Via Benzinga
    Benzinga's 'Stock Whisper' Index: 5 Stocks Investors Are Secretly Monitoring But Not Talking About Yet
    Via Benzinga
    BioXcel Therapeutics, Alvotech And Other Big Stocks Moving Lower On Thursday
    Via Benzinga
    Why Franklin Covey Shares Are Trading Higher By 25%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
    Via Benzinga
    12 Health Care Stocks Moving In Thursday's Pre-Market Session
    Via Benzinga
    Why CorMedix Are Trading Lower By 22%; Here Are 20 Stocks Moving Premarket
    Via Benzinga
    Crude Oil Rises Sharply; Unifirst Earnings Miss Expectations
    Via Benzinga
    Data & News supplied by www.cloudquote.io
    Stock quotes supplied by Barchart
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.